10 hours ago
Europe Proteomics Research Report 2025: Market Insights, Competitive Landscape and Forecasts 2024-2034 Featuring Biognosys, DiaSorin, Merck, Oxford Expression Technologies
The Europe proteomics market is expected to rise to $27.43 billion by 2034 from $8.77 billion in 2024, with a CAGR of 12.07%. Driving this growth are advancements in mass spectrometry and next-gen sequencing technologies enhancing protein analysis precision. The increased focus on personalized healthcare, catalyzed by biomarker discovery and disease profiling, amplifies demand. Support from EU funding, public-private partnerships, and strategic alliances further propels market expansion. Europe's aging population and rising chronic diseases underscore the importance of proteomics in diagnostics and early detection. Key players include Biognosys AG, DiaSorin S.p.A., and Merck KGaA.
European Proteomics Market
Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Europe Proteomics Market: Focus on Offerings, Application, and Country - Analysis and Forecast, 2024-2034" report has been added to Europe proteomics market is projected to reach $27.43 billion by 2034 from $8.77 billion in 2024, growing at a CAGR of 12.07% during the forecast period 2024-2034. Advances in mass spectrometry and next-generation sequencing technologies, which provide ever-increasing precision in protein analysis, are driving the proteomics market's growth in Europe. Demand is further increased by a rise in personalised healthcare activities, which are fuelled by initiatives to find new biomarkers and improve disease profiling.
New proteomic applications are being accelerated by strong research funding from EU programs, expanding public-private partnerships, and strategic alliances between hospitals, biotech companies, and academia. In the meantime, Europe's ageing population and increasing prevalence of chronic diseases highlight the need for better diagnostics and early detection techniques, solidifying proteomics as a key component of the region's clinical innovation and life-science R&D market for proteomics in Europe is growing rapidly as more and more clinical labs, pharmaceutical companies, and life science researchers realise how effective protein-level analysis is in understanding disease causes, finding biomarkers, and speeding up drug development. Regional vendors and service providers are launching integrated systems that optimise workflows from sample input to data interpretation, driven by ongoing advancements in high-resolution mass spectrometry, microfluidic sample preparation, and advanced bioinformatics. The need for both discovery-scale and targeted proteomics solutions is being driven by the acceleration of translational projects in oncology, immunology, and neurodegeneration through public and private funding streams, ranging from national research efforts to Horizon Europe increasing access to state-of-the-art single-cell and spatial proteomics techniques, academic-industry clinic partnerships and consortia have made it possible for researchers to map cellular heterogeneity within tissue microenvironments and identify new therapeutic targets. Clinical laboratories are laying the groundwork for wider regulatory approval and reimbursement by progressively validating multiple response monitoring assays and label-free quantification for companion diagnostics and patient stratification. Infrastructure investments in core facilities and data-analysis skills are solidifying proteomics as a key component of personalised and precision medicine plans throughout Western Europe, the Nordics, and rising Eastern European the future, market players expect that further standardisation of protocols, improved interoperability between multi-omics data streams, and expanding collaborations with cloud computing providers will reduce entry barriers and open up new avenues for vaccine development, biomarker validation, and real-time therapeutic efficacy monitoring.
How can this report add value to an organization?Product/Innovation Strategy: The Europe proteomics market has been extensively segmented based on various categories, such as offering, application, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming Strategy: The Europe proteomics market has numerous established players with product and service portfolios. Key players in the Europe proteomics market analyzed and profiled in the study involve established players offering proteomics products and services.
Europe Proteomics Market Trends, Drivers and Challenges
Trends
Growing integration of high-resolution mass spectrometers with single-cell and spatial proteomics workflows
Expansion of multi-omics platforms combining proteomics with genomics and metabolomics
Increased adoption of label-free quantitation and data-independent acquisition for deeper proteome coverage
Emergence of cloud-based bioinformatics and AI-driven data analysis pipelines
Rising use of targeted proteomics (PRM/MRM) in clinical assay development
Drivers
Strong EU and national funding programmes supporting biomarker discovery and translational research
Demand for precision medicine solutions, including companion diagnostics and stratified patient care
Growth of academic-industry partnerships and consortia accelerating technology validation
Regulatory encouragement for advanced safety and efficacy testing in drug development
Pressure to improve early-stage disease detection and monitor therapeutic responses
Challenges
High capital and operational costs for state-of-the-art instrumentation and specialized personnel
Complex sample preparation workflows and variability across laboratories
Data management bottlenecks due to massive proteomic datasets and lack of harmonized standards
Limited clinical validation and regulatory pathways for proteomics-based diagnostics
Need for robust quality-control frameworks and inter-laboratory reproducibility studies
Key Market Players and Competition SynopsisThe companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market prominent names in the Europe proteomics market include:
Biognosys AG
DiaSorin S.p.A.
Merck KGaA
Oxford Expression Technologies Ltd.
Key Attributes:
Report Attribute
Details
No. of Pages
87
Forecast Period
2024 - 2034
Estimated Market Value (USD) in 2024
$8.77 Billion
Forecasted Market Value (USD) by 2034
$27.43 Billion
Compound Annual Growth Rate
12.0%
Regions Covered
Europe
Key Topics Covered: Executive SummaryScope and Definition1 Market1.1 Market Outlook1.1.1 Comparative Advantages and Disadvantages of Proteomics Over Other Omics1.1.2 Proteomics Techniques by Introduction with Principles and Advantages/Limitations1.2 Key Findings1.3 Europe Proteomics Market Scenario1.3.1 Realistic Scenario1.3.2 Optimistic Scenario1.3.3 Pessimistic Scenario1.4 Industry Outlook1.4.1 Supply Chain Overview1.5 Trends: Current and Future Impact Assessment1.5.1 Increasing Automation for End-to-End Proteomics Workflow1.5.2 Significant Number of Collaborations among Market Players1.5.3 Growing Proteomics Research to Identify Disease Biomarkers1.6 Patent Analysis1.6.1 Patent Filing Trend (by Country, Year)1.7 Regulatory Framework1.7.1 European Union (EU)1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices1.7.1.1.1 EU Medical Device Regulation1.7.1.1.2 EU In Vitro Diagnostic Regulation1.7.1.2 Regulatory Requirements for Clinical Proteomics Labs in the EU1.8 Product Benchmarking1.9 Market Dynamics Overview1.9.1 Market Drivers1.9.1.1 Increasing Prevalence of Chronic Diseases1.9.1.2 Increasing Technological Advancements1.9.1.3 Advancements in Personalized Medicine and Drug Discovery1.9.2 Market Restraints1.9.2.1 Shortage of Skilled Professionals1.9.2.2 Complexity in Analyzing Data of Proteomics Research1.9.3 Market Opportunities1.9.3.1 Progress in Nanoproteomics Platforms to Enhance and Thoroughly Analyze Natural Protein Complexes2 Proteomics Market (by Region), $Million, 2022-20342.1 Regional Summary2.2 Europe2.2.1 Regional Overview2.2.2 Driving Factors for Market Growth2.2.3 Factors Challenging the Market2.2.4 Europe Proteomics Market, by Application2.2.5 Europe Proteomics Market, by Offering2.2.5.1 Europe Proteomics Market, by Product2.2.6 France2.2.6.1 France Proteomics Market, by Application2.2.6.2 France Proteomics Market, by Offering2.2.6.2.1 France Proteomics Market, by Product2.2.7 Italy2.2.7.1 Italy Proteomics Market, by Application2.2.7.2 Italy Proteomics Market, by Offering2.2.7.2.1 Italy Proteomics Market, by Product2.2.8 Germany2.2.8.1 Germany Proteomics Market, by Application2.2.8.2 Germany Proteomics Market, by Offering2.2.8.2.1 Germany Proteomics Market, by Product2.2.9 U.K.2.2.9.1 U.K. Proteomics Market, by Application2.2.9.2 U.K. Proteomics Market, by Offering2.2.9.2.1 U.K. Proteomics Market, by Product2.2.10 Spain2.2.10.1 Spain Proteomics Market, by Application2.2.10.2 Spain Proteomics Market, by Offering2.2.10.2.1 Spain Proteomics Market, by Product2.2.11 Rest-of-Europe2.2.11.1 Rest-of-Europe Proteomics Market, by Application2.2.11.2 Rest-of-Europe Proteomics Market, by Offering2.2.11.2.1 Rest-of-Europe Proteomics Market, by Product3 Markets - Competitive Benchmarking & Company Profiles3.1 Proteomics Market: Competitive Landscape3.1.1 Corporate Strategies, January 2022-December 20243.1.2 Partnerships, Alliances, and Business Expansions3.1.3 Mergers and Acquisitions3.1.4 New Offerings3.2 Company Profiles3.2.1 Overview3.2.2 Top Products/ Services3.2.3 Top Competitors3.2.4 Target Customers3.2.5 Key Personnel3.2.6 Analyst View4 Research Methodology
For more information about this report visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
European Proteomics Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
